Impact of rare and common genetic variation in the Interleukin-1 pathway for human cytokine responses
Rosanne C van Deuren,
Maartje van de Vorst,
Leo AB Joosten,
Charles A Dinarello,
Musa M. Mhlanga,
Mihai G. Netea,
Frank L van de Veerdonk,
Posted 20 Feb 2020
bioRxiv DOI: 10.1101/2020.02.14.949602
Posted 20 Feb 2020
Interleukin(IL)-1 signaling is of major importance in human innate cytokine responses. Common variants in related genes have been linked to various inflammation-mediated diseases and stimulation-induced cytokine responses, but the role of rare variants remains to be elucidated. In this study, we characterize the role of rare and common genetic variation, as identified by molecular inversion probe-based sequencing, in 48 genes related to the IL-1 pathway. We examined the inter-individual variability in in vitro stimulation-specific human cytokine responses from 463 healthy individuals of the Human Functional Genomics Project and assessed the role of rare and common genetic variants, separately and combined, by means of the Sequence Kernel Association Test. We identified strong associations for rare genetic variants in NCF4 (adjP=7.2E-05) and CASP1 (adjP=3.0E-05) with IL-6 production in response to PHA and LPS stimulation, respectively. In addition, common variants in IL36A and IL38 were associated to both C. albicans -induced IL-1β ( IL36A adjP=0.0442; IL38 adjP=0.0092) and IL-6 production ( IL36A adjP=0.0037; IL38 adjP=0.0082), an effect that was stronger at the subpathway level both for IL-1β (adjP=0.0017) and IL-6 (adjP=1.8E-04). The common variant signature for the IL-1β and IL-6 response to C. albicans was confirmed by an association with all anti-inflammatory genes (adjP=1.87E-03 and adjP=5.75E-04), and we validated this finding for non-coding common variants. Lastly, we identified a burden of rare variants in pro-inflammatory genes and LPS-induced IL-6 production (adjP=2.42E-04), and a new role for anti-inflammatory rare variants on S. aureus -stimulated IL-6 production (adjP=6.71E-03). In conclusion, we show that both common and rare genetic variation in genes of the IL-1 pathway, separately and combined, differentially influence in vitro cytokine responses to various stimuli in healthy individuals. This study therefore provides insight into potential mechanisms that are translatable into new hypothesis-driven characterization of common and rare variant involvement in a wide variety of inflammatory and immunological mechanisms and diseases. ### Competing Interest Statement LABJ reports to be Scientific Advisory Board member of Olatec Therapeutics LLC. CAD serves as chair of SAB of Olatec Therapeutics LLC. All other authors declare that they have no conflict of interest.
- Downloaded 345 times
- Download rankings, all-time:
- Site-wide: 49,003 out of 92,759
- In systems biology: 1,435 out of 2,374
- Year to date:
- Site-wide: 8,756 out of 92,759
- Since beginning of last month:
- Site-wide: 14,005 out of 92,759
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!